CN Patent
CN112174989B — 一种克立硼罗的制备方法
Assigned to JIANGXI SYNERGY PHARMACEUTICAL CO Ltd · Expires 2023-06-20 · 3y expired
What this patent protects
本发明涉及一种结构式I的克立硼罗的制备方法,以间甲基苯酚为起始原料,经过五步反应得到目标产物。本发明所述制备方法起始原料及各步所用原料均廉价易得,工艺简单,苯环上引入硼原子进而形成氧硼杂环的反应新颖、收率高、条件温和,适合工业化生产。
USPTO Abstract
本发明涉及一种结构式I的克立硼罗的制备方法,以间甲基苯酚为起始原料,经过五步反应得到目标产物。本发明所述制备方法起始原料及各步所用原料均廉价易得,工艺简单,苯环上引入硼原子进而形成氧硼杂环的反应新颖、收率高、条件温和,适合工业化生产。
Drugs covered by this patent
- Eucrisa (Crisaborole) · Anacor Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.